314 related articles for article (PubMed ID: 32164621)
1. High tumor budding is a strong predictor of poor prognosis in the resected perihilar cholangiocarcinoma patients regardless of neoadjuvant therapy, showing survival similar to those without resection.
Ito T; Kuriyama N; Kozuka Y; Komatsubara H; Ichikawa K; Noguchi D; Hayasaki A; Fujii T; Iizawa Y; Kato H; Tanemura A; Murata Y; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S
BMC Cancer; 2020 Mar; 20(1):209. PubMed ID: 32164621
[TBL] [Abstract][Full Text] [Related]
2. Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.
Sallinen V; Sirén J; Mäkisalo H; Lehtimäki TE; Lantto E; Kokkola A; Nordin A
Scand J Surg; 2020 Sep; 109(3):219-227. PubMed ID: 30791825
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status.
Kuriyama N; Usui M; Gyoten K; Hayasaki A; Fujii T; Iizawa Y; Kato H; Murata Y; Tanemura A; Kishiwada M; Sakurai H; Mizuno S; Isaji S
BMC Cancer; 2020 May; 20(1):405. PubMed ID: 32393197
[TBL] [Abstract][Full Text] [Related]
4. Optimal indications for additional resection of the invasive cancer-positive proximal bile duct margin in cases of advanced perihilar cholangiocarcinoma.
Oguro S; Esaki M; Kishi Y; Nara S; Shimada K; Ojima H; Kosuge T
Ann Surg Oncol; 2015; 22(6):1915-24. PubMed ID: 25404474
[TBL] [Abstract][Full Text] [Related]
5. Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case-control study with propensity score matching.
Noji T; Tsuchikawa T; Okamura K; Tanaka K; Nakanishi Y; Asano T; Nakamura T; Shichinohe T; Hirano S
J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):442-8. PubMed ID: 27207604
[TBL] [Abstract][Full Text] [Related]
6. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.
Higuchi R; Yazawa T; Uemura S; Izumo W; Furukawa T; Yamamoto M
J Hepatobiliary Pancreat Sci; 2017 Aug; 24(8):456-465. PubMed ID: 28547855
[TBL] [Abstract][Full Text] [Related]
7. Surgery for perihilar cholangiocarcinoma from a viewpoint of age: Is it beneficial to octogenarians in an aging society?
Akashi K; Ebata T; Mizuno T; Yokoyama Y; Igami T; Yamaguchi J; Onoe S; Nagino M
Surgery; 2018 Nov; 164(5):1023-1029. PubMed ID: 30082134
[TBL] [Abstract][Full Text] [Related]
8. Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: A propensity score matching analysis of resectable perihilar cholangiocarcinoma.
Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
Surgery; 2017 Feb; 161(2):394-404. PubMed ID: 27712872
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of the site of portal vein invasion in patients with surgically resected perihilar cholangiocarcinoma.
Nakanishi Y; Tsuchikawa T; Okamura K; Nakamura T; Tamoto E; Murakami S; Ebihara Y; Kurashima Y; Noji T; Asano T; Shichinohe T; Hirano S
Surgery; 2016 Jun; 159(6):1511-1519. PubMed ID: 26948498
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma: an appraisal and comparison with left hepatectomy.
Natsume S; Ebata T; Yokoyama Y; Igami T; Sugawara G; Shimoyama Y; Nagino M
Ann Surg; 2012 Apr; 255(4):754-62. PubMed ID: 22367444
[TBL] [Abstract][Full Text] [Related]
12. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach.
Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
Surgery; 2018 Apr; 163(4):732-738. PubMed ID: 29336813
[TBL] [Abstract][Full Text] [Related]
13. Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme.
Bagante F; Tran T; Spolverato G; Ruzzenente A; Buttner S; Ethun CG; Groot Koerkamp B; Conci S; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Vitiello G; IJzermans JN; Maithel SK; Poultsides G; Guglielmi A; Pawlik TM
J Am Coll Surg; 2016 May; 222(5):750-759.e2. PubMed ID: 27113512
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of additional resection of a margin-positive distal bile duct in perihilar cholangiocarcinoma.
Otsuka S; Ebata T; Yokoyama Y; Mizuno T; Tsukahara T; Shimoyama Y; Ando M; Nagino M
Br J Surg; 2019 May; 106(6):774-782. PubMed ID: 30889275
[TBL] [Abstract][Full Text] [Related]
15. Impact of tumour budding grade in 310 patients who underwent surgical resection for extrahepatic cholangiocarcinoma.
Ogino M; Nakanishi Y; Mitsuhashi T; Hatanaka Y; Amano T; Marukawa K; Nitta T; Ueno T; Ono M; Kuwabara S; Yamada T; Hirano S
Histopathology; 2019 May; 74(6):861-872. PubMed ID: 30667537
[TBL] [Abstract][Full Text] [Related]
16. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections.
Nagino M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Takahashi Y; Nimura Y
Ann Surg; 2013 Jul; 258(1):129-40. PubMed ID: 23059502
[TBL] [Abstract][Full Text] [Related]
17. Surgical Outcomes for Perihilar Cholangiocarcinoma with Vascular Invasion.
Higuchi R; Yazawa T; Uemura S; Izumo W; Ota T; Kiyohara K; Furukawa T; Egawa H; Yamamoto M
J Gastrointest Surg; 2019 Jul; 23(7):1443-1453. PubMed ID: 30203230
[TBL] [Abstract][Full Text] [Related]
18. Stratification of Postoperative Prognosis by Invasive Tumor Thickness in Perihilar Cholangiocarcinoma.
Oba M; Nakanishi Y; Amano T; Okamura K; Tsuchikawa T; Nakamura T; Noji T; Asano T; Tanaka K; Hirano S
Ann Surg Oncol; 2021 Apr; 28(4):2001-2009. PubMed ID: 33040247
[TBL] [Abstract][Full Text] [Related]
19. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.
Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
J Hepatobiliary Pancreat Sci; 2016 Oct; 23(10):636-642. PubMed ID: 27474781
[TBL] [Abstract][Full Text] [Related]
20. Surgical resection for Bismuth type IV perihilar cholangiocarcinoma.
Ebata T; Mizuno T; Yokoyama Y; Igami T; Sugawara G; Nagino M
Br J Surg; 2018 Jun; 105(7):829-838. PubMed ID: 28488733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
